Illumina Accounts Payable

Illumina (ILMN) currently reports a accounts payable of $230M as of June 2026. That compares with $200M in the prior-year period — up 15.0% year over year. Use the charts on this page to explore Illumina's accounts payable history and peer comparisons.

Illumina's accounts payable increased from $200M to $230M — a 15.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Illumina reported $230M in accounts payable as of June 2026. That compares with $200M in the prior-year period — up 15.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Illumina, and consider following ILMN for alerts when major investors trade the stock.

Illumina is classified in the Healthcare sector. On accounts payable, it currently shows $230M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ILMN with unrelated industries.